Ahmed Abdulhameed Mohammad

Novel therapeutics in myelodysplastic syndromes / بحث حول الأساليب العلاجية الحديثة لمتلازمة خلل النخاع Ahmed Abdulhameed Mohammad ; Supervised Mona M. Elkassas , Mona Elhuseiny Abufarha - Cairo : Ahmed Abdulhameed Mohammad , 2010 - 123P. : facsimiles ; 25cm

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine

Myelodysplastic syndromes ( MDS ) entails a series of hematologic conditions characterized by chronic cytopenias and abnormal cellular maturation . Although supportive treatment remains the main approach advances in understanding pathogenesis of MDS have generated novel strategies for management Refinements in determining critical prognostic parameters have led to improved understanding the natural history and treatment of MDS



Epigenetic modifiers Myelodysplastic syndromes Novel therapies